Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Days Sales Outstanding : 5,280.06 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Great Novel Therapeutics Biotech & Medicals Days Sales Outstanding?

Great Novel Therapeutics Biotech & Medicals's average Accounts Receivable for the six months ended in Dec. 2023 was NT$2.55 Mil. Great Novel Therapeutics Biotech & Medicals's Revenue for the six months ended in Dec. 2023 was NT$0.09 Mil. Hence, Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding for the six months ended in Dec. 2023 was 5,280.06.

The historical rank and industry rank for Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding or its related term are showing as below:

ROCO:7427' s Days Sales Outstanding Range Over the Past 10 Years
Min: 6.92 Med: 6.92 Max: 191.61
Current: 191.61

During the past 6 years, Great Novel Therapeutics Biotech & Medicals's highest Days Sales Outstanding was 191.61. The lowest was 6.92. And the median was 6.92.

ROCO:7427's Days Sales Outstanding is ranked worse than
82.97% of 881 companies
in the Biotechnology industry
Industry Median: 72.67 vs ROCO:7427: 191.61

Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding increased from Dec. 2022 (0.00) to Dec. 2023 (5,280.06).

Great Novel Therapeutics Biotech & Medicals Days Sales Outstanding Historical Data

The historical data trend for Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Novel Therapeutics Biotech & Medicals Days Sales Outstanding Chart

Great Novel Therapeutics Biotech & Medicals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

6.92

Great Novel Therapeutics Biotech & Medicals Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial					174.20	-	-	191.62	5,280.06

Competitive Comparison of Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding

For the Biotechnology subindustry, Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding falls into.

Great Novel Therapeutics Biotech & Medicals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0.092)	/	1 )	/	4.85	*	365
=	0.092					/	4.85	*	365
=	6.92

Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (5	+	0.092)	/	2 )	/	0.088	*	365 / 2
=	2.546					/	0.088	*	365 / 2
=	5,280.06

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Great Novel Therapeutics Biotech & Medicals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Great Novel Therapeutics Biotech & Medicals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Great Novel Therapeutics Biotech & Medicals (ROCO:7427) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.3, Park Street, Room WR-06, 17th Floor, Nangang District, Taipei, TWN, 11503

Website

http://www.gntbm.com.tw

Great Novel Therapeutics Biotech & Medicals focuses on drug development to treat advanced cancer. The new drugs ranging from epigenetic modulators, a combination of tumor microenvironment-regulating agents, epigenetic immuno-modulators, to the protein degradation drugs targeting HDACs 1, 2, and 3, are in a developing pipeline. These drugs focus on the field of epigenetics, for the demand of clinical unmet needs in advanced and refractory cancers.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Headlines

No Headlines